Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.1%

- Check33 days agoChange DetectedGlossary toggle controls were added (Show glossary / Hide glossary) and the footer now includes a revision tag (Revision: v3.4.0) along with updated QC criteria text and a No FEAR Act Data notice.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a metadata update rather than a modification of study content.SummaryDifference0.1%

- Check69 days agoChange DetectedA new Locations section is added, listing Illinois and Tennessee study sites (Illinois and Tennessee), consolidating location details.SummaryDifference0.3%

- Check90 days agoChange DetectedPubMed publications note updated to say they are automatically filled from PubMed, and the revision indicator now shows v3.3.2 (replacing v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.